High-level CLDN6 expression is commonly detectable in germ cell tumors (GCT), epithelial ovarian cancer (EOC), endometrial carcinoma and additional solid tumor indications, including rare malignancies. This evidence concerns the gene CLDN6 and granular cell tumor.